Sign in
Active, not recruitingNo phase

Diagnostic Value of EBUS-Guided Transbronchial Mediastinal Cryobiopsy Versus Conventional Bronchoscopic Approaches for Stage I/II Sarcoidosis

Key facts

Who runs it
China-Japan Friendship Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
469 people, planned
Started
1 Mar 2026
Expected to end
Dec 2026
Type of study
Interventional, 2 groups
Treatments tested
  • EBUS-TBNA-based sampling methods
  • EBUS-TBMC based sampling method
Record updated
6 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Age ≥18years
  • Patients with clinical and radiological suspicion of stage I or stage II sarcoidosis
  • Fully informed of the purpose and method of the study

Who cannot take part

  • Pathologically confirmed sarcoidosis, obvious organ involvement with the possibility of confirming granulomas using a minimally invasive diagnostic procedure
  • Patients with medical contraindications to bronchoscopy procedures

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), combined with endobronchial biopsy (EBB) and/or transbronchial lung biopsy (TBLB), and endobronchial ultrasound-guided transbronchial mediastinal cryobiopsy (EBUS-TBMC) have high diagnostic yields for patients with sarcoidosis. However, a direct comparison between them has not been conducted. This randomized controlled trial aims to compare directly the diagnostic yield between EBUS-TBMC and EBUS-TBNA+EBB+TBLB in sarcoidosis.

The 2 groups in the trial

  • EBUS-TBMCTreatment being tested

    Patients will receive endobronchial biopsy, transbronchial lung biopsy and EBUS-TBMC

    Treatment: EBUS-TBMC based sampling method

  • EBUS-TBNATreatment being tested

    Patients will receive endobronchial biopsy, transbronchial lung biopsy and EBUS-TBNA

    Treatment: EBUS-TBNA-based sampling methods

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
6 August 2026